Home › Diabetic Eye Problems › California › Sacramento
Diabetic Eye Problems clinical trials in Sacramento, CA
3 studies for Diabetic Eye Problems are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
RecruitingPhase 3
- Retinal Consultants Medical Group ( Site 0013), Sacramento
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
RecruitingPhase 3
- Retinal Consultants Medical Group ( Site 0015), Sacramento
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
RecruitingPhase 2/3
- Retinal Consultants - Sacramento - Greenback Lane /ID# 283018, Sacramento
About Diabetic Eye Problems
Diabetic eye problems such as diabetic retinopathy can harm your vision and sometimes cause blindness. It is important to manage your diabetes and get regular eye exams.
More about Diabetic Eye Problems on MedlinePlus
Diabetic Eye Problems trials in other cities
- San Antonio, TX4 studies
- San Francisco, CA3 studies
- Birmingham, AL3 studies
- Baltimore, MD3 studies
- Hagerstown, MD3 studies
- Austin, TX3 studies
- Houston, TX3 studies
- Bakersfield, CA3 studies
- Chicago, IL3 studies
- Carmel, IN3 studies
- Raleigh, NC3 studies
- Glendale, CA3 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer23 studies
- Prostate Cancer20 studies
- Breast Cancer19 studies
- Metastatic Cancer17 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure12 studies
- Colon Cancer12 studies
- Cancer (all types)11 studies
- Colorectal Cancer11 studies
- Pancreatic Cancer11 studies
- Bladder Cancer10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.